Halozyme Therapeutics shares owned by Clark Capital Management Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Clark Capital Management Group
from 13F filings
Historical chart of Clark Capital Management Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Clark Capital Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Clark Capital Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 203k | 73.34 |
| 2025-06-30 | $9.2M | 177k | 52.02 |
| 2025-03-31 | $13M | 206k | 63.81 |
| 2024-12-31 | $8.5M | 179k | 47.81 |
| 2024-09-30 | $7.9M | 137k | 57.24 |
| 2024-06-30 | $5.4M | 103k | 52.36 |
| 2023-03-31 | $1.1M | 30k | 38.19 |
| 2022-12-31 | $2.0M | 35k | 56.90 |
| 2022-09-30 | $1.3M | 34k | 39.55 |
| 2022-06-30 | $1.5M | 34k | 44.01 |
| 2021-12-31 | $2.2M | 55k | 40.20 |
| 2021-09-30 | $2.4M | 58k | 40.68 |
More positions owned by Clark Capital Management Group
View all positions for Clark Capital Management Group